SCHEMBL6634828

SCHEMBL6634828

CCCN(C)Cc1c[c]ccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.42
PRMT6 Q96LA8 1/20 0.42
PRMT8 Q9NR22 1/20 0.42
SIGMAR1 Q99720 3/20 0.41
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
MAOB P27338 4/20 0.34
TSHR P16473 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 3/20 0.33
MAOA P21397 2/20 0.33
USP2 O75604 1/20 0.33
CYP3A4 P08684 1/20 0.33
PYCR1 P32322 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6638418 0.87 SIGMAR1 (0.49) CARM1PRMT6PRMT8SIGMAR1MAOB
SCHEMBL7140660 0.85 CHRNB2 (0.50) CARM1PRMT6PRMT8SIGMAR1CHRNB2
SCHEMBL2645309 0.81 ALDH1A1 (0.49) CARM1PRMT6PRMT8SIGMAR1MAOB
SCHEMBL27947941 0.81 CARM1 (0.50) CARM1PRMT6PRMT8SIGMAR1MAOB
SCHEMBL6667357 0.81 HRH3 (0.43) MAOBTSHRKDM4E
SCHEMBL1041217 0.79 TSHR (0.54) CHRNB2CHRNA4TSHRALDH1A1
SCHEMBL6634540 0.77 MAPT (0.50)
SCHEMBL172637 0.77 CARM1 (0.67) CARM1PRMT6PRMT8SIGMAR1MAOB
SCHEMBL6638680 0.76 KCNH2 (0.45)
SCHEMBL6634552 0.76 ADRA2B (0.44) SIGMAR1MAOBTSHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165557-B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORP (US) 2004-09-29 EP claimed
US-6627624-B1 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome, NEUROGEN CORPORATION 2003-09-30 US claimed
EP-1165557-B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORP (US) 2004-09-29 EP disclosed